Literature DB >> 29046795

Comparison of clinicopathological characteristics between cirrhotic and non-cirrhotic patients with intrahepatic cholangiocarcinoma: A large-scale retrospective study.

Lei Yuan1, Xianwu Luo1, Xinyuan Lu2, Bin Yi1, Kaijian Chu1, Quanyu Cai3, Xiaoqing Jiang1.   

Abstract

The effect of cirrhosis on the characteristics of intrahepatic cholangiocarcinoma (ICC) has not been fully elucidated. The purpose of this study was to investigate how cirrhosis affects the clinicopathological characteristics and survival of surgically treated ICC patients. A total of 1,312 ICC patients surgically treated between January 2007 and December 2011 at a single institution were retrospectively reviewed and the clinicopathological data were compared between cirrhotic and non-cirrhotic patients. Univariate and multivariate analyses were performed to identify significant and independent prognostic factors in this cohort. A total of 302 patients (23.0%) were cirrhotic. Compared with cirrhotic patients, the tumors in non-cirrhotic patients were usually larger, less differentiated, and more likely to have lymphatic metastasis, vascular and perineural invasion. Following resection, cirrhotic patients achieved a longer survival compared with non-cirrhotic patients (16.0 vs. 13.0 months, respectively; P<0.038). Multivariate analysis demonstrated that hepatitis B virus infection and cirrhosis were independent favorable prognostic factors, while the presence of cholelithiasis, elevated carbohydrate antigen 19-9 and carcinoembryonic antigen levels, multiple tumors, lymphatic metastasis, vascular invasion and positive surgical margin status were independent unfavorable prognostic factors. Overall, the clinicopathological characteristics of ICC patients with and without cirrhosis differed significantly. Compared with cirrhotic patients, in whom the biological behavior of ICC was similar to that of HCC, non-cirrhotic patients exhibited higher-risk pathological characteristics, lower curative resection rate and worse survival.

Entities:  

Keywords:  cirrhosis; intrahepatic cholangiocarcinoma; surgical resection; survival

Year:  2017        PMID: 29046795      PMCID: PMC5639306          DOI: 10.3892/mco.2017.1387

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  29 in total

1.  Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection.

Authors:  Durgatosh Pandey; Kang-Hoe Lee; Chun-Tao Wai; Gajanan Wagholikar; Kai-Chah Tan
Journal:  Ann Surg Oncol       Date:  2007-08-10       Impact factor: 5.344

Review 2.  Classification of chronic viral hepatitis: a need for reassessment.

Authors:  P J Scheuer
Journal:  J Hepatol       Date:  1991-11       Impact factor: 25.083

3.  Survival outcomes and prognostic factors of surgical therapy for all potentially resectable intrahepatic cholangiocarcinoma: a large single-center cohort study.

Authors:  Xianwu Luo; Lei Yuan; Yi Wang; Ruiliang Ge; Yanfu Sun; Gongtian Wei
Journal:  J Gastrointest Surg       Date:  2014-01-07       Impact factor: 3.452

4.  Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States.

Authors:  Vivekanandan Perumal; Jianzhou Wang; Paul Thuluvath; Michael Choti; Michael Torbenson
Journal:  Hum Pathol       Date:  2006-07-18       Impact factor: 3.466

Review 5.  Hepatocellular carcinoma in cirrhosis: incidence and risk factors.

Authors:  Giovanna Fattovich; Tommaso Stroffolini; Irene Zagni; Francesco Donato
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

Review 6.  Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms.

Authors:  Christian Bréchot
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

7.  Prognostic value of cirrhosis for intrahepatic cholangiocarcinoma after surgical treatment.

Authors:  Ya-yong Li; Hao Li; Pin Lv; Gang Liu; Xiao-rong Li; Bu-ning Tian; Dao-jin Chen
Journal:  J Gastrointest Surg       Date:  2011-01-19       Impact factor: 3.452

8.  Changing international trends in mortality rates for liver, biliary and pancreatic tumours.

Authors:  Shahid A Khan; Simon D Taylor-Robinson; Mireille B Toledano; Angus Beck; Paul Elliott; Howard C Thomas
Journal:  J Hepatol       Date:  2002-12       Impact factor: 25.083

9.  Impact of hepatitis B virus infection on outcome following resection for intrahepatic cholangiocarcinoma.

Authors:  Lei Zhang; Jian-Qiang Cai; Jian-Jun Zhao; Xin-Yu Bi; Xiao-Gang Tan; Tao Yan; Cong Li; Ping Zhao
Journal:  J Surg Oncol       Date:  2010-03-01       Impact factor: 3.454

10.  Epidemiology and Prevention of Hepatitis B Virus Infection.

Authors:  Jinlin Hou; Zhihua Liu; Fan Gu
Journal:  Int J Med Sci       Date:  2005-01-05       Impact factor: 3.738

View more
  2 in total

1.  Ablative therapies for intrahepatic cholangiocarcinoma.

Authors:  Antonio Giorgio; Pietro Gatti; Paolo Matteucci; Valentina Giorgio
Journal:  Hepatobiliary Surg Nutr       Date:  2018-06       Impact factor: 7.293

2.  Prognostic impact of hepatitis B or C on intrahepatic cholangiocarcinoma.

Authors:  Jung Woong Seo; Byung Soo Kwan; Young Koog Cheon; Tae Yoon Lee; Chan Sup Shim; So Young Kwon; Won Hyeok Choe; Byung Chul Yoo; Jeong Min Yoon; Jung Hoon Lee
Journal:  Korean J Intern Med       Date:  2020-01-10       Impact factor: 2.884

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.